Ítem
Solo Metadatos
Infections and vaccines in the etiology of antiphospholipid syndrome
dc.creator | Cruz-Tapias, Paola | spa |
dc.creator | Blank, Miri | spa |
dc.creator | Anaya, Juan-Manuel | spa |
dc.creator | Shoenfeld, Yehuda | spa |
dc.date.accessioned | 2020-05-26T00:05:45Z | |
dc.date.available | 2020-05-26T00:05:45Z | |
dc.date.created | 2012 | spa |
dc.description.abstract | Purpose of review: To present scientific evidence supporting the infectious origin for the antiphospholipid syndrome (APS) by molecular mimicry between pathogens, infection and vaccination with ?2-glycoprotein I (?2-GPI) molecule. Recent findings: APS is characterized by the presence of pathogenic autoantibodies against ?2-GPI. The infection etiology of APS was well established. Likewise, a link between vaccination such as tetanus toxoid may trigger antibodies targeting tetanus toxoid and ?2-GPI, due to molecular mimicry between the two molecules. During the years, the pathogenic potential of anti-tetanus toxoid antibodies cross reactive with ?2-GPI were found to be pathogenic in animal models, inducing experimental APS. Summary: Accumulated evidence supports that the presence of anti-?2-GPI antibodies is associated with a history of infections and the main mechanism to explain this correlation is molecular mimicry. The relationship between tetanus toxoid vaccination and APS reveals a novel view on the autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA). © 2012 Wolters Kluwer Health | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1097/BOR.0b013e32835448b8 | |
dc.identifier.issn | 15316963 | |
dc.identifier.issn | 10408711 | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/23823 | |
dc.language.iso | eng | spa |
dc.relation.citationEndPage | 393 | |
dc.relation.citationIssue | No. 4 | |
dc.relation.citationStartPage | 389 | |
dc.relation.citationTitle | Current Opinion in Rheumatology | |
dc.relation.citationVolume | Vol. 24 | |
dc.relation.ispartof | Current Opinion in Rheumatology, ISSN:15316963, 10408711, Vol.24, No.4 (2012); pp. 389-393 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862149521&doi=10.1097%2fBOR.0b013e32835448b8&partnerID=40&md5=283b8aa73cebb6a83a3f0832195b9b68 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | 4 aminobutyric acid | spa |
dc.subject.keyword | immunologic | eng |
dc.subject.keyword | Aluminum hydroxide | spa |
dc.subject.keyword | Beta2 glycoprotein 1 | spa |
dc.subject.keyword | Beta2 glycoprotein 1 antibody | spa |
dc.subject.keyword | Cardiolipin antibody | spa |
dc.subject.keyword | Diphtheria antibody | spa |
dc.subject.keyword | Ganglioside antibody | spa |
dc.subject.keyword | Glycerol | spa |
dc.subject.keyword | Immunoglobulin a antibody | spa |
dc.subject.keyword | Immunoglobulin g antibody | spa |
dc.subject.keyword | Immunoglobulin m antibody | spa |
dc.subject.keyword | Interleukin 1 receptor | spa |
dc.subject.keyword | Laminin | spa |
dc.subject.keyword | Myeloid differentiation factor 88 | spa |
dc.subject.keyword | Tetanus toxoid | spa |
dc.subject.keyword | Toll like receptor | spa |
dc.subject.keyword | Antibody production | spa |
dc.subject.keyword | Antiphospholipid syndrome | spa |
dc.subject.keyword | Autoinflammatory disease | spa |
dc.subject.keyword | Blood clotting time | spa |
dc.subject.keyword | Clostridium tetani | spa |
dc.subject.keyword | Cross reaction | spa |
dc.subject.keyword | Enzyme linked immunosorbent assay | spa |
dc.subject.keyword | Fetus wastage | spa |
dc.subject.keyword | Human | spa |
dc.subject.keyword | Infection | spa |
dc.subject.keyword | Medical history | spa |
dc.subject.keyword | Molecular mimicry | spa |
dc.subject.keyword | Nonhuman | spa |
dc.subject.keyword | Partial thromboplastin time | spa |
dc.subject.keyword | Priority journal | spa |
dc.subject.keyword | Review | spa |
dc.subject.keyword | Signal transduction | spa |
dc.subject.keyword | Tetanus prophylaxis | spa |
dc.subject.keyword | Thrombocytopenia | spa |
dc.subject.keyword | Adjuvants | eng |
dc.subject.keyword | Antiphospholipid syndrome | spa |
dc.subject.keyword | Autoantibodies | spa |
dc.subject.keyword | Beta 2-glycoprotein i | spa |
dc.subject.keyword | Cross reactions | spa |
dc.subject.keyword | Humans | spa |
dc.subject.keyword | Infection | spa |
dc.subject.keyword | Molecular mimicry | spa |
dc.subject.keyword | Tetanus toxoid | spa |
dc.subject.keyword | ?2-glycoprotein i | spa |
dc.subject.keyword | Antiphospholipid syndrome | spa |
dc.subject.keyword | Tetanus toxoid | spa |
dc.title | Infections and vaccines in the etiology of antiphospholipid syndrome | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |